Cavatak
Cavatak is the other name or brand name for coxsackievirus A21. Cavatak is an innovative drug, primarily designed to combat various forms of cancers, with a specific emphasis on metastatic melanoma. It is currently undergoing clinical trials to gauge its efficacy, safety, and potential advantages in the realm of cancer treatments.
Development[edit | edit source]
The inception of Cavatak is rooted in years of intensive research and development in the field of oncology. Recognizing the need for advanced treatments for cancer patients, especially those diagnosed with metastatic melanoma, led to the discovery and subsequent development of this promising drug.
Clinical Trials[edit | edit source]
In-depth clinical trials are pivotal to the acceptance and eventual market release of any drug. Cavatak is currently under extensive clinical trials across various stages, focusing on its application in metastatic melanoma and other types of cancers. These trials are vital to ensure not just the drug's efficacy, but also its safety profile when administered to patients.
Results[edit | edit source]
While the complete results of these trials are awaited, preliminary data has shown promising outcomes, indicating potential benefits of Cavatak in treating cancer, especially metastatic melanoma.
Orphan Drug Status[edit | edit source]
In recognition of its potential utility in treating advanced melanoma, Cavatak was awarded the prestigious Orphan Drug status in December 2005. This designation is not just a testament to the drug's potential therapeutic significance but also offers various incentives and regulatory benefits, thus accelerating its path to market availability.
See Also[edit | edit source]
References[edit | edit source]
- Anderson, L. (2006). Metastatic Melanoma: Emerging Treatments. Oncology Today.
- Cavatak Clinical Trials - Official website detailing the stages, progress, and results of Cavatak clinical trials.
| Cavatak Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
